2024-11-25 18:31:03
Innovent Announces NMPA Acceptance of New Drug Application for the FGFR1/2/3 Inhibitor (Pemigatinib) for the Treatment of Adults with Previously Treated, Unresectable Locally Advanced or Metastatic Cholangiocarcinoma with a FGFR2 Fusion or Rearrangement
Corporate/ 2023-07-23
Innovent Announces NMPA Acceptance of Ne...

SAN FRANCISCO,and SUZHOU,China,July 9,2021-- Innovent Biologics,Inc. (Innovent) (HKEX: 01801),a world-class biopharmaceutical company that d...

BRI Deploys Teras BRI Ships to Provide Vaccination in the Maluku Islands
Corporate/ 2023-07-23
BRI Deploys Teras BRI Ships to Provide V...

MANADO,Indonesia,July 10,2021-- PT Bank Rakyat Indonesia (Persero) Tbk (IDX:BBRI) is committed to supporting the success of the COVID-19 vac...

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release